Noven's drug for bipolar disorder Stavzor gets US FDA approval
Monday, August 04, 2008 15:00 IST Miami, Florida
Noven Pharmaceuticals, Inc announced that the US Food and Drug Administration (FDA) has approved Stavzor (valproic acid delayed release capsules) in 125 mg, 250 mg and 500 mg strengths.
